Background: Gastrointestinal (GI) bleeding can result from various conditions, including ulcers, neoplasms and infectious enterocolitis. The aim of this study was to evaluate the utility of the fecal immunochemical transferrin test compared with the fecal Hb test in various clinical settings. Methods: A total of 1,116 clinical stool specimens submitted for fecal occult blood testing were prospectively examined using both FIT Hb and FIT Tf kits (AlfresaPharma, Japan). To verify the specificity of the two tests, stool specimens from 265 health check-up examinees were also included. Results: A review of medical records revealed that 396 patients had clinical conditions associated with GI bleeding. FIT Hb and FIT Tf results were positive in 156 (39.4%) and 137 (34.6%) cases, respectively, and an additional 194 (49.0%) cases tested positive with either FIT Hb or FIT Tf. The two tests showed a moderate strength of agreement (kappa value; 0.56). Colitis (n=71) was associated with the most GI bleedings, followed by acute gastroenteritis (n=29), GI ulcers (n=27) and GI cancers (n=15). While the first two groups had higher positive rates on FIT Tf, patients in the latter two groups had higher positive rates on FIT Hb. Notably, four of nine specimens from premature babies tested positive only on FIT Tf. The specificity of FIT Hb and FIT Tf was 100% and 99.6%, respectively. Conclusion: Concurrent use of FIT Hb and FIT Tf improved the detection rate of occult GI bleeding, especially in patients with infectious GI disease (such as colitis or gastroenteritis) and in premature babies.
INTRODUCTION
Gastrointestinal (GI) bleeding can occur due to various conditions including ulcer disease, esophagitis, varices, vascular lesions, neoplasm, diverticula, hemorrhoids, fissures, inflammatory bowel disease and infectious colitis [1] . Fecal occult blood tests (FOBTs) represent simple and non-invasive methods for the detection of GI bleeding. The three classes of FOBTs include: guaiac-based tests, heme-porphyrin tests, and immunochemical tests, all of which have limited sensitivities and specificities [2] . Recently, the fecal immunochemical test for hemoglobin (FIT Hb) has been widely used due to its higher sensitivity compared with older forms of FOBTs and the test re-sults are not influenced by food or medications [3, 4] . FIT Hb is based on antibodies against the protein component of intact human globin in feces [5] . However, the globin is easily degraded by enterobacteria and digestive enzymes, and therefore, less sensitive for detection of upper GI bleeding. Transferrin (Tf), which is a serum β-globulin that binds and transports iron [6] , can leaks into the GI tract during GI bleeding and it can be detected in feces. It is more stable than hemoglobin to digestive enzymes [7] , and it can be a potential marker for GI bleeding [3, 8] . Several studies have shown that the combined use of both fecal Tf and Hb as biomarkers results in higher rates of positivity in colorectal cancer screening [3, 9] . However, its utility in various clinical conditions of GI bleeding has not been 
MATERIALS AND METHODS

Study subjects
From August to October 2016, a total of 1,381 stool specimens (1,116 specimens from patients and 265 specimens from health check-up) submitted to clinical microbiology laboratory for examination of occult blood were included. The demographic characteristics of the participants are listed in Table 1 .
We reviewed the medical records of all patients to identify the clinical conditions. This study was approved by the institutional review board of Seoul St. Mary's Hospital. and FIT Tf were 100 ng/mL (20 μg/g feces) and 50 ng/mL (10 μg/g feces), respectively.
Fecal immunochemical test
Statistical analysis
Statistical analyses were performed using MedCalc (v. 16.4.3) .
To compare the positive rates of the two tests, the McNemar test was used and statistical significance was established at P＜ 0.05. Spearman correlation analysis was used to evaluate the correlation between assays, and inter-rater agreement (kappa value) was calculated.
RESULTS
Results from the general health check-up
The median values of FIT Hb and FIT Tf were 3.0 (25%-75%: 2.0-5.0) and 1.0 (25%-75%: 0.0-2.0) ng/mL, respectively ( Table 1 ). All the specimens tested were negative for FIT Hb and only a single specimen was positive for FIT Tf (131 ng/mL). However, colonoscopy and esophagogastroduodenoscopy examination of the examinee showed no specific lesions. Therefore, the specificities of FIT Hb and FIT Tf were 100% (95% CI: 98.6-100.0) and 99.6% (95% CI: 97.9-100.0), respectively. Of the 265 health check-up examinees, 132 subjects underwent colonoscopy and colon polyps were found in 72 cases. Pathological examinations were performed in 54 cases, all of which showed non-advanced adenoma.
Results from the clinical specimens
The demographic characteristics of the 1,116 patients and the median values of FIT Hb and FIT Tf are listed in Table 1 . Notably, although the number of specimens derived from premature births was small (n=9), the four specimens showed positive results only with FIT Tf . They were from four babies who had clinical conditions suggesting GI bleeding; one baby (gestational age (GA) of 32 weeks and 5 days) who showed FIT [13] reported that the sensitivity of fecal Tf dipstick was higher than that of IFOBT in colorectal cancer and premalignant lesions (76% vs. 61%). The differences in these studies might be derived from the difference in target population because while the tests were done as a cancer screening in previous studies, in our study, the tests were done as a follow up study after therapeutic resection. The other reason might be the difference in the test kits used.
The second and the third largest groups including colitis and AGE accounted for 7.2% (154/1,116) of all the clinical specimens submitted for FOBT, suggesting that GI symptoms such as abdominal pain or diarrhea were also a major indication of FOBT. The positive rate was the highest in these two groups (72.3% and 54.7%) and FIT Tf showed higher positive rates than FIT Hb (87/154 vs. 77/154). The higher positive rate of FIT Tf might be attributed to the higher stability of Tf and resistance to digestive enzymes and bacterial degradation [7] . A bloody stool can be seen in bacterial diarrhea but not in viral diarrhea [1] , and therefore, FOBT may aid clinicians in the identification of patients requiring hospitalization [14] , pathogen testing, and initiation of optimal antibiotic therapy. Further evaluation using FIT Tf involving enterocolitis of various causes is needed.
To our knowledge, this is the first study that evaluated fecal transferrin in specimens from premature babies. In premature babies, NEC, infectious colitis, congenital gut anomalies, bleeding disorders, vascular malformations, and specific medications are the common causes associated with GI bleeding [15, 16] .
Four out of nine cases showed positive results only with FIT Tf and two cases tested positive in both tests (positive rates of FIT Tf and FIT Hb were 100% and 33.3%, respectively, P=0.05). In addition, the fecal Tf levels of the latter two cases (5,104 ng/mL and 5,757 ng/mL) were much higher than those of the other cases (3,077 ng/mL, 545 ng/mL, 224 ng/mL and 151 ng/mL).
Although Tf concentration is known to be lower in younger children and lower GA [17, 18] , FIT Tf was still more sensitive than FIT Hb in detecting fecal occult blood in premature babies.
Our finding is in line with a previous study where routine FOBT targeting of fecal Hb adopted by many NICUs, did not predict NEC in very low-birth weight neonates [19] . We presume that it might be related to differences in globin components of fetal and adult Hb, because fetal Hb consists of 60-90% of total Hb until 1 month of age [20] . Considering the relatively high prevalence (5-6%) of NEC in babies with very low birth weight (＜1,500 grams), further studies investigating the utility of fecal TF in this population are imperative.
In summary, based on our study, both FIT Hb and FIT Tf were highly specific, and showed moderate correlation (rs= 0.601, P＜0.05) and low PPA (9.1%). According to the clinical conditions, FIT Hb was more sensitive to detecting non-infectious GI bleeding such as GI ulcer, cancer and anal bleeding, while FIT Tf was more sensitive for infectious GI bleeding such as colitis and acute gastroenteritis. In addition, the concentrations of both Hb and Tf can vary from person to person, so the use of both markers will be helpful to diminish the effect of individual variation [7] . Therefore, we hypothesize that testing FIT Hb alone is not sufficient to detect GI bleeding, and the concurrent use of FIT Tf is essential to improve the detection of GI bleeding, especially in patients with colitis, gastroenteritis and premature babies.
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